AVAHHealthcare · Medical Care FacilitiesThe 11 Wall Street analysts covering Aveanna Healthcare Holdings, Inc. hold a median 12-month price target of $13 — +5.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 88 of 100 as at 15 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Aveanna Healthcare Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (99): The shares have been drifting up relative to others.
Accruals (23): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on AVAH, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +5.5% from it.
Of the 20 most recent actions, 5 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 14 Aug 2026 | BMO Capital | Maintains | Outperform | $10 → $14 |
| 14 Aug 2026 | Raymond James | Maintains | Strong Buy | $13 → $15 |
| 14 Aug 2026 | UBS | Maintains | Neutral | $8.00 → $13 |
| 14 July 2026 | Truist Securities | Maintains | Hold | $9.00 → $11 |
| 9 July 2026 | Barclays | Maintains | Overweight | $9.00 → $9.50 |
| 3 June 2026 | RBC Capital | Upgrade | Outperform | — |
| 20 May 2026 | Truist Securities | Maintains | Hold | — |
| 18 May 2026 | Barclays | Maintains | Overweight | — |
| 15 May 2026 | RBC Capital | Maintains | Sector Perform | — |
| 15 May 2026 | Stephens & Co. | Upgrade | Overweight | — |
| 13 Apr 2026 | Truist Securities | Maintains | Hold | — |
| 25 Mar 2026 | Barclays | Maintains | Overweight | — |
| 23 Mar 2026 | RBC Capital | Maintains | Sector Perform | — |
| 20 Mar 2026 | BMO Capital | Maintains | Outperform | — |
| 20 Mar 2026 | Truist Securities | Maintains | Hold | — |
| 16 Jan 2026 | Barclays | Maintains | Overweight | — |
| 15 Jan 2026 | RBC Capital | Maintains | Sector Perform | — |
| 15 Jan 2026 | UBS | Maintains | Neutral | — |
| 8 Dec 2025 | William Blair | Initiates | Outperform | — |
| 13 Nov 2025 | BMO Capital | Initiates | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AVAH appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 60% of US stocks
Cheaper than 69% of US stocks
Cheaper than 12% of US stocks
Cheaper than 29% of US stocks
Higher than 60% of US stocks
Higher than 75% of US stocks
Higher than 37% of US stocks
Higher than 68% of US stocks
Higher than 71% of US stocks
Higher than 98% of US stocks
Higher than 92% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Aveanna Healthcare Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Aveanna raised its 2026 outlook and long-term growth targets during its Q2 earnings call, citing reimbursement gains and preferred payers as factors supporting expansion.
Why it matters — A raised growth outlook signals Aveanna's confidence in its reimbursement environment and payer mix, which are key drivers of its home healthcare business.
Aveanna Healthcare Holdings Inc. (AVAH) published its Q2 2026 earnings call transcript, as covered by Seeking Alpha. The transcript documents the company's second-quarter earnings discussion.
Why it matters — An AVAH watcher would care because the earnings call transcript provides direct insight into the company's quarterly financial performance and management commentary.
Aveanna Healthcare Holdings reported strong Q2 2026 results, beating earnings and revenue estimates while significantly raising its full-year EBITDA and revenue guidance.
Why it matters — Aveanna watchers would note the company's strong earnings beat, raised guidance, and attractive valuation relative to peers, though gross margin declines across segments warrant attention.
Aveanna Healthcare reported higher second-quarter revenue and adjusted EBITDA, supported by growth across its three divisions, improved reimbursement rates, higher volumes and operational efficiencies. The company also raised its full-year outlook and updated long-term organic growth targets for its Private Duty Services and Home Health and Hospice businesses.
Why it matters — The results and raised guidance signal continued operational growth and improved profitability, which AVAH watchers would view as a favorable development for the company's trajectory.
Zacks examined Aveanna's (AVAH) Q2 earnings for the quarter ended June 2026, noting that while revenue and EPS give a sense of business performance, key metrics were compared against Wall Street estimates and year-ago figures.
Why it matters — Aveanna watchers would care because the report assesses how the company's key metrics stacked up against analyst expectations for the quarter.
The 11 Wall Street analysts covering Aveanna Healthcare Holdings, Inc. have a median 12-month price target of $13, with estimates ranging from $8 to $16. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 11 analysts covering Aveanna Healthcare Holdings, Inc., 8 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Aveanna Healthcare Holdings, Inc. 88 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 15 Aug 2026, Aveanna Healthcare Holdings, Inc. ranks 88 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (99 of 100).
No one can know that. What the data says: the median 12-month target from 11 analysts implies +5.5% from the last close, and Ticker Nerd's factor model ranks Aveanna Healthcare Holdings, Inc. 88 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Aveanna Healthcare Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AVAH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $8 to $16 over the next 12 months.
Aveanna Healthcare Holdings, Inc. returned +71.1% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Aveanna Healthcare Holdings Inc. is a diversified home care platform specializing in services for medically complex, high-cost patient populations across the United States.
The most recent item we track (Zacks Investment Research, 14 Aug 2026): "AVAH Q2 Earnings Call Highlights Higher Growth Targets". Aveanna raised its 2026 outlook and long-term growth targets during its Q2 earnings call, citing reimbursement gains and preferred payers as factors supporting expansion.
Aveanna Healthcare Holdings Inc. is a diversified home care platform specializing in services for medically complex, high-cost patient populations across the United States. It operates through three primary segments: Private Duty Services, offering skilled pediatric and adult nursing, therapy, and personal care in patients' homes; Home Health & Hospice, providing comprehensive home health and end-of-life care; and Medical Solutions, delivering enteral nutrition and related products. The company emphasizes clinical excellence, technology-enabled operations, and strong partnerships with managed care and government payers to facilitate efficient transitions from acute care settings to home environments. Aveanna Healthcare Holdings Inc. serves children and adults nationwide through an extensive network of branches, focusing on high-quality, compassionate care that reduces institutional stays and improves patient outcomes. Founded in 2016 and headquartered in Atlanta, Georgia, it stands as a national leader in addressing critical home healthcare needs with innovative solutions and data-driven results.
CEO Mr. Jeffrey S. Shaner · 3,500 employees · United States · https://www.aveanna.com